In preclinical studies, spray offered nearly 100% protection from respiratory infections by COVID-19, influenza, viruses, and pneumonia-causing bacteria
COVID-19 has not only sickened and killed millions around the globe, it has wreaked havoc on existing programs to fight health ills that affect millions more. Harvard T.H. Chan School of Public Health Dean Michelle Williams discusses with the Gazette an “action agenda” on global health for the incoming Biden administration.
Thomas Hübl, founder of the Academy of Inner Science, will offer a three-part workshop to Harvard faculty and staff to help them cope with the demands of the COVID-19 pandemic.
Evidence of a post-Thanksgiving surge should be emerging this week, a Harvard epidemiologist said, advising people who gathered together to get tested or assume they’re infected.
Experts said the complex rollout of a coronavirus vaccine gives the U.S. a chance for a win after the virus gained the upper hand in its initial phase.
Barry Bloom from the Harvard T.H. Chan School of Public Health offers context about the news that two experimental vaccines appear to confer a high level of protection from the coronavirus.
Massachusetts General Hospital researchers examined six patients using a specialized magnetic resonance technique and found that COVID-19 patients with neurological symptoms show some of the same metabolic disturbances in the brain as patients who have suffered oxygen deprivation from other causes.
A new study describes how a 12-minute burst of cardio exercise impacted more than 80 percent of circulating metabolites, including pathways linked key bodily functions such as insulin resistance, oxidative stress, vascular reactivity, inflammation, and longevity.
For COVID-19, the difference between surviving and not surviving severe disease may be due to the quality, not the quantity, of the patients’ antibody development and response, suggests a new study.
As part of our series, artificial intelligence is examined through the medical lens. It may lift personalized treatment, fill gaps in access to care, and cut red tape, but risks abound.
Medical experts say a vaccine will be a key development in the fight against the coronavirus, but warned against thinking its deployment will mean the fight is over.
A new trial at Beth Israel Deaconess Medical Center is aiming to disrupt COVID-19’s attack early in its course by treating patients immediately after symptoms appear with a widely used antiviral drug that, if it works, could be rapidly repurposed to fight the coronavirus.
College students of color not only face a disproportionate risk of contracting COVID-19, they are particularly vulnerable to its psychological damage — especially when the longtime struggle against inequality and the current financial crisis are factored in, said speakers at a virtual Harvard forum.
Looking at the public health effects, and perhaps mortality rate, from President Trump’s running dismissal of wearing face masks to minimize the spread of coronavirus.
Risk factors for heart health, such as smoking, unhealthy diets and minimal physical activity, may seem personal, but for people who are married or in a domestic partnership, the behavior patterns of one person may be strongly linked to the patterns of the other.
Harvard Chan School’s Joseph Allen gives America an “F” on school reopening efforts, and says we’re in danger of losing thousands of virtual dropouts and wasting mild late summer/early autumn weather we could use to boost in-person learning.
Two days after the 2016 presidential election, hospitalization rates for heart attacks and strokes were 1.62 times higher than the same two days the week prior, based on information supplied by a large southern California health system.
The international forum “Global Perspectives on COVID-19,” co-sponsored by Harvard Medical School, cited the importance of strong, coordinated government response as a key to stopping the novel coronavirus’ spread.
The TestBoston study will facilitate at-home testing on 10,000 people for both the SARS-CoV-2 virus and antibodies against it to increase access to testing and surveillance.